CBIO vs IOVA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CBIO

47.9
AI Score
VS
IOVA Wins

IOVA

60.6
AI Score

Investment Advisor Scores

CBIO

48score
Recommendation
HOLD

IOVA

61score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CBIO IOVA Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 80.1% IOVA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 47.9/100 60.6/100 IOVA
Profit Margin 0.0% -58.2% CBIO
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CBIO 1M: -3.7% · 3M: -15.3% IOVA 1M: -44.5% · 3M: +20.0%

Current Technical Phase

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.6 · Price: $13.92

IOVA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 34

RSI (14): 33.6 · Price: $8.09

Fundamentals Snapshot

Metric CBIO IOVA
Market Cap — —
Forward P/E -5.3 -54.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.8%
Gross Margin 1.0% 0.5%
Operating Margin -14.3% -0.2%
EPS -7.63 -0.49
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IOVA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.